Ignite Creation Date:
2024-05-05 @ 10:26 PM
Last Modification Date:
2024-10-26 @ 10:18 AM
Study NCT ID:
NCT01107977
Status:
COMPLETED
Last Update Posted:
2016-11-28
First Post:
2010-04-20
Brief Title:
Iyengar Yoga for Young People With Irritable Bowel Syndrome
Sponsor:
University of California Los Angeles
Organization:
University of California Los Angeles
Study Overview
Official Title:
Iyengar Yoga for Young People With Irritable Bowel Syndrome
Status:
COMPLETED
Status Verified Date:
2016-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Irritable bowel syndrome IBS affects as many as 14 of high school-aged students Symptoms include discomfort in the abdomen along with diarrhea andor constipation and other gastroenterological symptoms which can significantly impact quality of life and daily functioning of patients Emotional stress appears to exacerbate IBS symptoms suggesting that mind-body interventions reducing arousal may prove beneficial Often symptoms can be traced to childhood and adolescence making the early manifestation of IBS important to understand The current study focuses on young people aged 14-26 years of age with IBS The study will test the potential benefits of Iyengar yoga IY on clinical symptoms psychospiritual functioning and visceral sensitivity Yoga is thought to bring physical psychological and spiritual benefits to practitioners and has been associated with reduced stress and pain Through its focus on restoration and use of props IY is especially designed to decrease arousal and promote psychospiritual resources in physically compromised individuals Sixty-four IBS patients aged 14-26 will be randomly assigned to a standardized 6-week biweekly IY group-based program 15 hour sessions or a wait-list usual care control group The groups will be compared on the primary clinical outcomes of IBS symptoms quality of life and global improvement at post-treatment and 2 month follow-up Secondary outcomes will include visceral pain sensitivity assessed with a standardized laboratory task water load task and psychospiritual variables including coping self-efficacy mood acceptance and mindfulness It is hypothesized that IY will be safe and feasible with less than 20 attrition and the IY group will demonstrate significantly improved outcomes compared to controls with physiological and psychospiritual mechanisms contributing to improvements clinical treatment gains will be maintained at 2 months following yoga
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None